Abstract
A number of C-terminal acyclic peptide intermediates of oxytocin (the tripeptide, L-prolyl-L-leucylglycinamide; the tetrapeptide, S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide; the octapeptide, L-tyrosyI-L-isoleucy-L-glutamnyl-L-asparaginyl-S-benzyl-L-cysteinly-L-prolyl-L-leucylglycinamide, and the hydrobromides of the tetrapeptide, S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide; the pentapeptide, L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide; the hexapeptide, L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamede; and the heptapeptide, L-isoleycyl-L-glutaminyl-L-asparaginyl-S-benzy-L-cysteinyl-L-prolyl-L-leucylcina mide) were synthesized, purified and evaluated for agonistic and antagonistic properties in an in vitro rat uterus assay system. All intermediates were found to be devoid of agonistic activity. However, the tetra- and octapeptide fragments antagonized the uterotonic action of oxytocin. The tetrapeptide proved to be a competitive antagonist of oxytocin activity at low dosage (1-7 x 10-4 M) with a PA2 of 4.20, but a noncompetitive, reversible inhibitor at high dosage (8-10 x 10-4 M). The octapeptide proved to be a competitive antagonist with a PA2 of 5.70 throughout the entire dosage range studied (3-36 x 10-6 M). These observations are discussed in relation to the in vivo degradation of oxytocin and the chemical topographical and chemical functional requirements for inhibitory action of these acycic intermediates of oxytocin.
Footnotes
- Received October 24, 1967.
- Accepted January 30, 1968.
- © 1968 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|